References
- Zuberbier T., Bindslev‐Jensen C., Canonica W., Grattan C. E. H., Greaves M. W., Henz B. M., et al. EAACI/GA2LEN/EDF guideline: Definition, classification and diagnosis of urticaria. Allergy 2006; 61: 316–20
- Natbony S. F., Phillips M. E., Elias J. M., Godfrey H. P., Kaplan A. P. Histologic studies of chronic urticaria. J Allergy Clin Immunol 1983; 71: 177–83
- Haas N., Toppe E., Henz B. M. Microscopic morphology of different types of urticaria. Arch Dermatol 1998; 134: 41–6
- Ying S., Kikuchi Y., Meng Q., Kay A. B., Kaplan A. P. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: Comparison with the allergen‐induced late‐phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694–700
- Kitao A., Nobuhara S., Kore‐Eda S., Takahashi K., Nishigori C., Miyachi Y. Persistent urticaria‐urticarial reaction caused by late phase reaction?. Eur J Dermatol 2001; 11: 440–2
- Charlesworth E. N. Urticaria and angioedema: A clinical spectrum. Ann Allergy Asthma Immunol 1996; 76: 484–95
- Kitao A., Nishigori C., Miyachi Y. Late‐phase urticaria Update. Curr Allergy Asthma Rep 2002; 2: 288–91
- Zuberbier T., Bindslev‐Jensen C., Canonica W., Grattan C. E., Greaves M. W., Henz B. M., et al. EAACI/GA2LEN/EDF guideline: Management of urticaria. Allergy 2006; 61: 321–31
- Toppe E., Haas N., Henz B. M. Neutrophilic urticaria: Clinical features, histological changes and possible mechanisms. Br J Dermatol 1998; 138: 248–53
- Hennino A., Berard F., Guillot I., Saad N., Rozieres A., Nicolas J. F. Pathophysiology of urticaria. Clin Rev Allergy Immunol 2006; 30: 3–11
- Zuberbier T., Greaves M. W., Juhlin L., Kobza‐Black A., Maurer D., Stingl G., et al. Definition, classification, and routine diagnosis of urticaria: A consensus report. J Investig Dermatol Symp Proc 2001; 6: 123–7
- Di Lorenzo G., Pacor M. L., Mansueto P., Esposito‐Pellitteri M., Ditta V., Lo Bianco C., et al. Is there a role for antileukotrienes in urticaria?. Clin Exp Dermatol 2006; 31: 327–34
- Bagenstose S. E., Levin L., Bernstein J. A. The addition of zafirlukast to cetirizine improves the treatment of chronicurticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113: 134–40
- Goel A., Prasad D. Oral montelukast in urticaria induced by nonsteroidal anti‐inflammatory drugs. J Eur Acad Dermatol Venereol, (2007). Published online: 25 May 2007. URL: http://www.blackwell‐synergy.com/doi/full/10.1111/j.1468‐3083.2007.02168.x DOI: 10.1111/j.1468‐3083.2007.02168.x
- Sanada S., Tanaka T., Kameyoshi Y., Hide M. The effectiveness of montelukast for the treatment of anti‐histamine resistant chronic urticaria. Arch Dermatol Res 2005; 297: 134–8
- Staumont‐Salle D., Dombrowi C. Z. D., Caproni M., Delaporte E. Eosinophils and urticaria. Clin Rev Allergy Immunol 2006; 30: 13–18
- Borstad G. C., Bryant L. R., Abel M. P., Scroggie D. A., Harris M. D., Alloway J. A. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004; 31: 2429–32
- Sullivan T. P., King L. E Jr., Boyd A. S. Colchicine in dermatology. J Am Acad Dermatol 1998; 39: 993–9
- Oka T., Hori M., Ozaki H. Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway. J Immunol 2005; 174: 4584–9
- Pfeiffer C., Wozel G. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol 2001; 45: 420–34
- Boehm I., Bauer R., Bieber T. Urticaria treated with dapsone. Allergy 1999; 54: 765–6
- Cassano N., D'Argento V., Filotico R., Vena G. A. Low‐dose dapsone in chronic idiopathic urticaria: Preliminary results of an open study. Acta Derm Venereol 2005; 85: 254–5